Charles Schwab’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-355,296
| Closed | -$5.38M | – | 3598 |
|
|
2022
Q3 | $5.38M | Buy |
355,296
+7,275
| +2% | +$110K | ﹤0.01% | 2180 |
|
|
2022
Q2 | $2.61M | Buy |
348,021
+7,302
| +2% | +$54.8K | ﹤0.01% | 2477 |
|
|
2022
Q1 | $3.1M | Buy |
340,719
+15,737
| +5% | +$143K | ﹤0.01% | 2494 |
|
|
2021
Q4 | $2.28M | Buy |
324,982
+27,597
| +9% | +$194K | ﹤0.01% | 2663 |
|
|
2021
Q3 | $3.39M | Sell |
297,385
-18,267
| -6% | -$208K | ﹤0.01% | 2554 |
|
|
2021
Q2 | $5.05M | Buy |
315,652
+16,851
| +6% | +$270K | ﹤0.01% | 2349 |
|
|
2021
Q1 | $5.34M | Buy |
298,801
+13,945
| +5% | +$249K | ﹤0.01% | 2269 |
|
|
2020
Q4 | $3.85M | Buy |
284,856
+2,767
| +1% | +$37.4K | ﹤0.01% | 2346 |
|
|
2020
Q3 | $3.32M | Buy |
282,089
+15,706
| +6% | +$185K | ﹤0.01% | 2279 |
|
|
2020
Q2 | $3.93M | Buy |
266,383
+2,698
| +1% | +$39.8K | ﹤0.01% | 2134 |
|
|
2020
Q1 | $3.56M | Buy |
263,685
+5,291
| +2% | +$71.4K | ﹤0.01% | 2004 |
|
|
2019
Q4 | $6.25M | Buy |
258,394
+7,751
| +3% | +$187K | ﹤0.01% | 1909 |
|
|
2019
Q3 | $4.82M | Buy |
250,643
+15,730
| +7% | +$302K | ﹤0.01% | 1976 |
|
|
2019
Q2 | $6.94M | Buy |
234,913
+16,668
| +8% | +$493K | ﹤0.01% | 1813 |
|
|
2019
Q1 | $10.4M | Buy |
218,245
+12,359
| +6% | +$587K | 0.01% | 1563 |
|
|
2018
Q4 | $7.43M | Sell |
205,886
-1,327
| -0.6% | -$47.9K | 0.01% | 1655 |
|
|
2018
Q3 | $12.8M | Buy |
207,213
+7,554
| +4% | +$465K | 0.01% | 1470 |
|
|
2018
Q2 | $13.5M | Buy |
199,659
+17,314
| +9% | +$1.17M | 0.01% | 1385 |
|
|
2018
Q1 | $9.89M | Buy |
182,345
+17,740
| +11% | +$962K | 0.01% | 1505 |
|
|
2017
Q4 | $9.84M | Buy |
164,605
+11,937
| +8% | +$713K | 0.01% | 1486 |
|
|
2017
Q3 | $7.42M | Buy |
152,668
+14,379
| +10% | +$699K | 0.01% | 1652 |
|
|
2017
Q2 | $7.27M | Buy |
138,289
+2,183
| +2% | +$115K | 0.01% | 1568 |
|
|
2017
Q1 | $6.17M | Buy |
136,106
+1,388
| +1% | +$63K | 0.01% | 1633 |
|
|
2016
Q4 | $5.1M | Buy |
134,718
+29,050
| +27% | +$1.1M | 0.01% | 1725 |
|
|
2016
Q3 | $3.99M | Buy |
105,668
+68,124
| +181% | +$2.57M | ﹤0.01% | 1795 |
|
|
2016
Q2 | $661K | Buy |
37,544
+7,700
| +26% | +$136K | ﹤0.01% | 2494 |
|
|
2016
Q1 | $363K | Hold |
29,844
| – | – | ﹤0.01% | 2707 |
|
|
2015
Q4 | $727K | Hold |
29,844
| – | – | ﹤0.01% | 2498 |
|
|
2015
Q3 | $530K | Buy |
29,844
+200
| +0.7% | +$3.55K | ﹤0.01% | 2594 |
|
|
2015
Q2 | $524K | Buy |
29,644
+13,644
| +85% | +$241K | ﹤0.01% | 2659 |
|
|
2015
Q1 | $502K | Hold |
16,000
| – | – | ﹤0.01% | 2621 |
|
|
2014
Q4 | $468K | Hold |
16,000
| – | – | ﹤0.01% | 2643 |
|
|
2014
Q3 | $332K | Hold |
16,000
| – | – | ﹤0.01% | 2751 |
|
|
2014
Q2 | $397K | Buy |
16,000
+4,800
| +43% | +$119K | ﹤0.01% | 2733 |
|
|
2014
Q1 | $238K | Hold |
11,200
| – | – | ﹤0.01% | 2893 |
|
|
2013
Q4 | $202K | Buy |
+11,200
| New | +$202K | ﹤0.01% | 2953 |
|